Dear Analytical Scientist,
-
What would you do if the FDA implemented Genotoxic Degradation guidelines tomorrow? Are you prepared to meet these guidances? Uncover the European Genotoxic Degradation guidances and what position the FDA is taking through presentations and case studies presented by Transform Pharmaceuticals and Pfizer R&D.
-
Are you maximizing the usefulness of your forced degradation testing results when designing your formulation? Hear a two-part case study from Merck on what information to take away from forced degradation to value in your formulation and method.
-
Are you certain that the orthogonal methods you are using to analyze forced degradation work are the most efficient? Are you leveraging the most effective combination of orthogonal methods? Grasp the benefits of improved orthogonal method utilization with case studies from Johnson & Johnson, Pfizer, and Arena Pharmaceuticals. Ask the experts during a panel discussion on the best orthogonal methods to implement when analyzing degradants.
-
Do you want to discover faster ways to conduct forced degradation? Improve your forced degradation testing efficiencies by hearing case studies on high throughput and automated technologies presented by Pfizer, Novartis, and Purdue University.
-
Do you have a pressing forced degradation challenge that you want to share? Bring forward your challenges during Therapy Time for Forced Degradation Testing and have the audience help you with the sharing of suggested solutions.
This is your chance to enhance your forced degradation knowledge with 12+ brand new case studies, and to engage in open dialogue with fellow analytical scientists through interactive breakout sessions, panel discussions, and therapy time.
IIR welcomes you to Forced Degradation 2008. Come and take advantage of this outstanding opportunity to hear and learn from the experts and develop relationships with other professionals in your field. WE look forward to greeting you in Baltimore!
Sincerely,
Tricia Carle
Conference Producer
Institute for International Research
Eric Nelson, PhD
Group Leader
Johnson & Johnson
Conference Co-Chairman
Alex Opio, PhD
Scientist
Pfizer, Inc.
Conference Co-Chairman